VMLY&Rx
VMLY&Rx is the Rx pharmaceutical specialty division of WPP-owned VML Health, providing brand experience, commerce, consulting, and medical communications services to pharmaceutical, biotech, and healthcare system clients globally through dedicated offices across North America, Europe, and Asia-Pacific.
- Company typePrivate
- Founded2020
- HeadquartersCambridge, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What VMLY&Rx does
VMLY&Rx is the prescription pharmaceutical specialty division within VML Health, a global healthcare communications network owned by WPP. Founded in 2020 and headquartered in Cambridge, Massachusetts, the firm targets pharmaceutical and biotech companies developing breakthrough therapies, alongside healthcare systems and select health non-profits. It operates as a B2B professional services agency delivering brand experience, commerce, consulting, customer experience, and technology transformation services, supplemented by health-specific capabilities including early commercialization, health equity, medical communications, patient engagement and advocacy, and payer marketing. The division's stated differentiator is 'radical empathy' — a positioning emphasizing deep understanding of healthcare professionals and patient lived experiences.
The business generates revenue through project-based fees, retainers, and consulting engagements negotiated on a per-engagement basis, distributed via direct enterprise field sales and relationship-based account management. Delivery is executed through dedicated VML Health offices in New York, London (also the European hub), Manchester, Sydney, Shanghai, Tokyo, Madrid, Barcelona, Milan, Paris, Frankfurt, and Zurich, integrated within VML's broader 124-office global network. Named enterprise clients include Sanofi (global corporate reputation campaign), Bayer (women's health), biotech firm Aritium, and non-profits F**k Cancer and Europa Donna. Technology infrastructure leverages WPP Open and broader WPP data/AI capabilities; no proprietary AI platform or technology product is disclosed. The firm ranks #3 in MM+M's 2026 Top 100 Healthcare Marketing Companies and produces the annual Health Futures trend report as proprietary thought leadership IP.
VMLY&Rx firmographics
Firmographics- Name
- VMLY&Rx
- Legal name
- VML
- Website
- https://vmlyrx.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- VMLY&Rx is the Rx pharmaceutical specialty division of WPP-owned VML Health, providing brand experience, commerce, consulting, and medical communications services to pharmaceutical, biotech, and healthcare system clients globally through dedicated offices across North America, Europe, and Asia-Pacific.
- Ownership category
- akta.pro rank
VMLY&Rx industry classification
Industry- Product category
- Healthcare Communications Services
- NAICS
- Custom Computer Programming Services (541511)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)
Keywords
Where VMLY&Rx is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices12 records
Markets served
VMLY&Rx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Healthcare Communications Services: Professional services revenue model providing healthcare communications, brand experience, consulting, customer experience, and technology transformation services to pharmaceutical companies, biotech firms, and healthcare systems. Revenue is generated through project-based fees, retainers, and consulting engagements rather than product sales.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
VMLY&Rx product offering
Product offeringCore offering
VML Health (VMLY&Rx) is a global healthcare communications network that provides integrated marketing, brand experience, commerce, consulting, customer experience, and technology transformation services to pharmaceutical, biotech, and healthcare organizations. The agency combines creative communications, medical expertise, and patient-centric strategy to help clients navigate the complex healthcare landscape and drive measurable outcomes across the product lifecycle.
Product overview
VML Health is a global healthcare communications network that creates connected brands for life. The company operates as a unified platform integrating VML's core capabilities—Brand Experience, Commerce, Consulting, Customer Experience, and Technology Transformation—with specialized health sector focus. Additionally, VML Health offers health-specific services including Early Commercialization, Health Equity, Medical Communications, Patient Engagement & Advocacy, and Payer Marketing. The company also produces the annual Health Futures Report, which identifies key healthcare trends shaping the industry.
Differentiator
Problem solved
Functional benefit
Products and services
- Healthcare Marketing & Brand Communications
- Medical Communications
- Patient Engagement Services
- Healthcare Consulting
- Customer Experience & Technology Transformation
- Market Access Communications
Companies that use VMLY&Rx
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
VMLY&Rx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
VMLY&Rx partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- WPPcoreVML Health is a WPP company ('A WPP Company'). VML Health leverages WPP's broader technology infrastructure including WPP Open's AI capabilities for patient insights and outcomes optimization. This parent company relationship provides institutional backing and access to WPP's global resources and client network.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
VMLY&Rx competitors and assessment
Company assessmentDirect peers
- Publicis Health: Publicis Groupe's healthcare communications arm and a direct holding-company peer. Competes head-to-head with VML Health on enterprise pharma pitches, medical communications, and patient engagement mandates.
- Omnicom Health Group: Omnicom Group's healthcare marketing network and a structurally identical peer: a holding-company-owned, multi-agency healthcare communications platform serving the same enterprise pharmaceutical client base.
- IPG Health: Interpublic Group's dedicated healthcare communications network. Directly comparable as a holding-company-owned healthcare marketing specialist competing for the same global pharma clients and offering similar service breadth.
- McCann Health: Global healthcare communications network and one of VML Health's most direct competitors. Both compete for the same enterprise pharma/biotech marketing mandates and offer comparable brand, medical communications, and patient engagement services at global scale.
- Syneos Health Communications: Communications arm of Syneos Health, combining clinical/biopharmaceutical services with commercial communications. Comparable to VML Health on pharma commercialization, payer marketing, and medical communications work.
- CMI Media Group: Independent healthcare media and communications agency specializing in pharma and biotech. Directly comparable on enterprise pharma media planning, HCP engagement, and multichannel campaign execution.
- Havas Health & You: Havas' global healthcare communications network. Directly comparable in scope — multi-discipline pharma/biotech creative, medical communications, and patient engagement services for enterprise clients.
- Evoke (Huntsworth): Healthcare marketing and communications specialist (formerly part of Huntsworth, now under CD&R ownership). Competes with VML Health for pharma enterprise mandates across brand, medical, and patient engagement.
Broad incumbents
- GCI Health: Sibling WPP agency focused on healthcare communications and public relations. Operates within VML Health's own parent network; competes for overlapping pharma/biotech PR and communications mandates while also serving as a potential partner.
Emerging players
- Biolumina: Independent healthcare creative agency within the Omnicom network focused on specialty pharma and rare disease. Smaller in scale than VML Health but competes in the same high-value specialty pharma creative and brand engagement space.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
VMLY&Rx social profiles
Digital presenceVMLY&Rx financial estimates
Financial estimateRevenue estimate
Valuation estimate
VMLY&Rx leadership team
Management profileNumber of profiles
Profiles10 records
VMLY&Rx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VMLY&Rx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VMLY&Rx
What does VMLY&Rx do?
VML Health (VMLY&Rx) is a global healthcare communications network that provides integrated marketing, brand experience, commerce, consulting, customer experience, and technology transformation services to pharmaceutical, biotech, and healthcare organizations. The agency combines creative communications, medical expertise, and patient-centric strategy to help clients navigate the complex healthcare landscape and drive measurable outcomes across the product lifecycle.
Is VMLY&Rx a public or private company?
VMLY&Rx is a private company. It is classified as corporate owned and is currently operating.
When was VMLY&Rx founded?
VMLY&Rx was founded in 2020. It employs 5,001 to 10,000 people.
Where is VMLY&Rx based?
VMLY&Rx is headquartered in Cambridge, United States, in the North America region.
How does VMLY&Rx make money?
One revenue line is on record: healthcare Communications Services.
Who are VMLY&Rx's main competitors?
Direct peers on record are Publicis Health, Omnicom Health Group, IPG Health, McCann Health, Syneos Health Communications, CMI Media Group, Havas Health & You and Evoke (Huntsworth). GCI Health is listed as a broad incumbent. Biolumina is listed as an emerging player.
Does VMLY&Rx have an API?
No public API is recorded for VMLY&Rx.
What industry is VMLY&Rx in?
VMLY&Rx's product category is Healthcare Communications Services. Its primary akta.pro industry code is HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms. Its NAICS code is 541511 and its SIC code is 7370.